AR037870A1 - Metodo para determinar la actividad biologica de defibrotida - Google Patents

Metodo para determinar la actividad biologica de defibrotida

Info

Publication number
AR037870A1
AR037870A1 ARP020104901A ARP020104901A AR037870A1 AR 037870 A1 AR037870 A1 AR 037870A1 AR P020104901 A ARP020104901 A AR P020104901A AR P020104901 A ARP020104901 A AR P020104901A AR 037870 A1 AR037870 A1 AR 037870A1
Authority
AR
Argentina
Prior art keywords
defibrotide
plasmin
biological activity
determining
measured amount
Prior art date
Application number
ARP020104901A
Other languages
English (en)
Spanish (es)
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium Spa filed Critical Gentium Spa
Publication of AR037870A1 publication Critical patent/AR037870A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/968Plasmin, i.e. fibrinolysin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ARP020104901A 2001-12-17 2002-12-17 Metodo para determinar la actividad biologica de defibrotida AR037870A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01830770A EP1325962A1 (en) 2001-12-17 2001-12-17 A method for determining the biological activity of defibrotide

Publications (1)

Publication Number Publication Date
AR037870A1 true AR037870A1 (es) 2004-12-09

Family

ID=8184814

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104901A AR037870A1 (es) 2001-12-17 2002-12-17 Metodo para determinar la actividad biologica de defibrotida

Country Status (26)

Country Link
US (1) US7338777B2 (https=)
EP (2) EP1325962A1 (https=)
JP (1) JP4348192B2 (https=)
KR (1) KR100912424B1 (https=)
CN (1) CN100408690C (https=)
AR (1) AR037870A1 (https=)
AT (1) ATE480637T1 (https=)
AU (1) AU2002360945B2 (https=)
CA (1) CA2468877C (https=)
DE (1) DE60237639D1 (https=)
DK (1) DK1456404T3 (https=)
ES (1) ES2349509T3 (https=)
HR (1) HRP20040548A2 (https=)
HU (1) HUP0402231A3 (https=)
IL (2) IL162511A0 (https=)
IS (1) IS7312A (https=)
MX (1) MXPA04005958A (https=)
NO (1) NO20042972L (https=)
NZ (1) NZ533594A (https=)
PL (1) PL373243A1 (https=)
PT (1) PT1456404E (https=)
RS (1) RS63104A (https=)
RU (1) RU2323979C2 (https=)
UA (1) UA80104C2 (https=)
WO (1) WO2003052130A2 (https=)
ZA (1) ZA200404656B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1325962A1 (en) 2001-12-17 2003-07-09 Gentium S.p.A. A method for determining the biological activity of defibrotide
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
EP2637672B1 (en) 2010-11-12 2018-08-22 Gentium S.r.l. Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
ES2660969T5 (es) 2012-06-22 2021-09-03 Gentium S R L Método basado en euglobulina para determinar la actividad biológica de defibrotida
US9655761B2 (en) 2012-11-12 2017-05-23 Djo, Llc Orthopedic back brace
TWI615473B (zh) * 2013-11-26 2018-02-21 金提恩責任有限公司 用於測定去纖維蛋白多核苷酸的生物活性之基於優球蛋白的方法
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
RU2766143C2 (ru) * 2017-07-26 2022-02-08 Джентиум С.Р.Л. Жидкая композиция дефибротида для лечения и профилактики веноокклюзионной болезни
TW201909904A (zh) 2017-08-03 2019-03-16 愛爾蘭商爵士製藥愛爾蘭有限責任公司 高濃度調配物
CN112236149A (zh) 2018-04-12 2021-01-15 贾兹制药公司 用于预防和治疗细胞因子释放综合征和与免疫耗竭相关的神经毒性的去纤苷
US20220023533A1 (en) 2018-12-07 2022-01-27 Jazz Phrmaceticals Ireland Limited Subcutaneous delivery of high concentration formulations
EP4110287A1 (en) 2020-02-28 2023-01-04 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
TW202308659A (zh) 2021-05-06 2023-03-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
DE2812943C3 (de) * 1978-03-23 1981-05-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma
IT1170215B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
US5231006A (en) * 1986-10-16 1993-07-27 Behringwerke Aktiengesellschaft Method for the determination of plasminogen
IT1252174B (it) * 1991-12-09 1995-06-05 Crinos Industria Farmaco Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento
US5321006A (en) * 1992-12-09 1994-06-14 International Flavors & Fragrances Inc. Flavor and fragrance compositions produced using process for quantitatively and qualitatively substantially continuously analyzing the aroma emitted from a living fruit
CN1187201A (zh) * 1995-05-05 1998-07-08 生物药物研究与发展有限公司 血纤维蛋白交联和/或转谷氨酰胺酶的抑制剂
GB9719161D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd New therapeutic method
EP1325962A1 (en) 2001-12-17 2003-07-09 Gentium S.p.A. A method for determining the biological activity of defibrotide

Also Published As

Publication number Publication date
AU2002360945A1 (en) 2003-06-30
UA80104C2 (en) 2007-08-27
CN1612938A (zh) 2005-05-04
IL162511A (en) 2010-02-17
EP1325962A1 (en) 2003-07-09
HK1077332A1 (zh) 2006-02-10
WO2003052130A3 (en) 2004-01-15
ES2349509T3 (es) 2011-01-04
HRP20040548A2 (en) 2004-10-31
HUP0402231A2 (hu) 2005-01-28
CA2468877A1 (en) 2003-06-26
PL373243A1 (en) 2005-08-22
NZ533594A (en) 2006-03-31
JP2005512547A (ja) 2005-05-12
RS63104A (sr) 2006-10-27
ATE480637T1 (de) 2010-09-15
CA2468877C (en) 2012-03-20
KR100912424B1 (ko) 2009-08-14
CN100408690C (zh) 2008-08-06
MXPA04005958A (es) 2004-11-01
NO20042972L (no) 2004-07-14
US20050009131A1 (en) 2005-01-13
RU2323979C2 (ru) 2008-05-10
PT1456404E (pt) 2010-12-03
IS7312A (is) 2004-06-14
JP4348192B2 (ja) 2009-10-21
US7338777B2 (en) 2008-03-04
ZA200404656B (en) 2005-06-13
AU2002360945B2 (en) 2007-11-08
EP1456404A2 (en) 2004-09-15
IL162511A0 (en) 2005-11-20
KR20040090959A (ko) 2004-10-27
RU2004121962A (ru) 2005-05-10
DE60237639D1 (de) 2010-10-21
DK1456404T3 (da) 2010-11-01
EP1456404B1 (en) 2010-09-08
HUP0402231A3 (en) 2010-01-28
WO2003052130A2 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
AR037870A1 (es) Metodo para determinar la actividad biologica de defibrotida
BR9914648A (pt) Processo para monitorar ação medicamentosa deinibidor de proteasoma
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
AR038437A1 (es) Tintura permanente del cabello en dos pasos
AR053371A1 (es) Medicion de la actividad de trombina en sangre entera
BRPI0510617A (pt) uso de expressão de il-17 para prever inflamação de pele; processos de tratamento
ES2160716T3 (es) Procedimiento para estabilizar la respuesta de un biosensor.
ES2097781T3 (es) Metodo y composicion para la determinacion de iones cloruro en fluidos.
BRPI0509505A (pt) método e kit útil para branqueamento de uma superfìcie dental
FI20011887A7 (fi) Kantapäälaite ja -menetelmä
AR057419A1 (es) Dispositivo y metodo para rapidamente determinar la efectividad del procedimiento de esterilizacion o desinfeccion
PT1283907E (pt) Metodo para o diagnostico de cancros
BG105112A (bg) Средство с антидепресивно действие
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
BR112014031934A8 (pt) Método com base em euglobulina para determinar a atividade biológica de defibrotide
ES2148125T1 (es) Procedimiento de regulacion de la desinfeccion de liquidos.
MX169931B (es) Procedimiento para determinar la catividad de serinproteasas inhibidores de serinproteasas
WO2005055815A3 (en) Systems and methods for dynamic analysis of muscle function and metabolism
WO2006036737A3 (en) Methods for identifying new drug leads and new therapeutic uses for known drugs
ES2068325T3 (es) Metodo y juego o kit para determinar la actividad funcional de la proteina s en el plasma humano.
AR056125A1 (es) Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas
ES2058211T3 (es) Procedimiento para la auto-ejecucion de la cinetica de enzimas.
TR200201251T2 (tr) Omega zinciri tadil edilmiş 15-hidroksieikosatetraenoik asit türevleri ve bunların göz kurumasının iyileştirilmesi için kullanım yöntemleri
UY26179A1 (es) Amidas sustituidas del ácido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporación de adenosina.
BR0215452A (pt) Teste de proteìna tirosina-fosfatase (ptpase) altamente sensitivo com o emprego de 6,8-diflúor-4-metil-umbeliferilfosfato

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FB Suspension of granting procedure